-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Evolent Health, Lowers Price Target to $5

Benzinga·07/28/2026 16:03:03
Listen to the news
TD Cowen analyst Charles Rhyee maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $8 to $5.